Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats

International Journal of Neuropsychopharmacology

Volumn 17, Issue 5, 2014, Pages 807-818

  Zhang, Qingsheng ^a,b   He, Meng ^a,b   Deng, Chao ^a,b,c   Wang, Hongqin ^a,b   Lian, Jiamei ^a,b   Huang, Xu Feng ^a,b,c  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

Author keywords

Antipsychotic; food intake; ghrelin; schizophrenia; weight gain

Indexed keywords

ANOREXIGENIC AGENT; GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR 1A ANTAGONIST; NEUROPEPTIDE; OLANZAPINE; UNCLASSIFIED DRUG; BENZODIAZEPINE DERIVATIVE; CENTRAL NERVOUS SYSTEM AGENTS; GHRELIN RECEPTOR; GHRP-6, LYS(3)-; MESSENGER RNA; NEUROLEPTIC AGENT; OLIGOPEPTIDE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOOD INTAKE; HYPERPHAGIA; HYPOTHALAMUS; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STOMACH; UPREGULATION; WEIGHT GAIN; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; EATING; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM AGENTS; EATING; FEMALE; GHRELIN; HYPERPHAGIA; HYPOTHALAMUS; NEUROPEPTIDES; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GHRELIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS; UP-REGULATION; WEIGHT GAIN;

EID: 84895759139     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145713001697     Document Type: Article

References (71)

1. Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, Miyata H, Nakajima K, Fujiwara Y, Hosoda H, Kangawa K, Mori M, Doki Y (2010) Effects of ghrelin administration after total gastrectomy: A prospective, randomized, placebocontrolled phase II study. Gastroenterology 138:1312-1320
2. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association
3. Asakawa A, Inui A, Kaga T, Katsuura G, Fujimiya M, Fujino MA, Kasuga M (2003) Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 52:947-952
4. Australian Government National Health and Medical Research Council (2004) Australian code of practice for the care and use of animals for scientific purposes, 7th edn. Canberra: Australian Government
5. Basoglu C, Oner O, Gunes C, Semiz UB, Ates AM, Algul A, Ebrinc S, Cetin M, Ozcan O, Ipcioglu O (2010) Plasma orexin A, ghrelin, cholecystokinin, visfatin, leptin and agouti-related protein levels during 6-week olanzapine treatment in first-episode male patients with psychosis. Int Clin Psychopharmacol 25:165-171
6. Beck B, Richy S, Stricker-Krongrad A (2004) Feeding response to ghrelin agonist and antagonist in lean and obese Zucker rats. Life Sci 76:473-478
7. Center for Drug Evaluation and Research FDA (2005) Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers
8. Chen VC-H, Wang T-N, Lu M-L, Chou J-Y, Ju P-C, Wu J-Y, Lin Z-R, Ji T-T, Chou C-E, Lee C-T, Lai T-J (2011) Weight gain and ghrelin level after olanzapine monotherapy. Prog Neuro-Psychoph 35:632-635
9. Correll CU, Lencz T, Malhotra AK (2011) Antipsychotic drugs and obesity. Trends Mol Med 17:97-107
10. Cowley MA et al. (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649-661
11. Davey KJ, O'Mahony SM, Schellekens H, O'Sullivan O, Bienenstock J, Cotter PD, Dinan TG, Cryan JF (2012) Gender-dependent consequences of chronic olanzapine in the rat: Effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology 221:155-169
12. Deng C (2013) Effects of antipsychotic medications on appetite, weight, and insulin resistance. Endocrinol Metab Clin North Am 42:545-563
13. Deng C, Lian J, Pai N, Huang X-F (2012) Reducing olanzapine-induced weight gain side effect by using betahistine: A study in the rat model. J Psychopharmacol 26:1271-1279
14. Dickson SL, Egecioglu E, Landgren S, Skibicka KP, Engel JA, Jerlhag E (2011) The role of the central ghrelin system in reward from food and chemical drugs. Mol Cell Endocrinol 340:80-87
15. Druce MR, Wren AM, Park AJ, Milton JE, Patterson M, Frost G, Ghatei MA, Small C, Bloom SR (2005) Ghrelin increases food intake in obese as well as lean subjects. Int J Obes Relat Metab Disord 29:1130-1136
16. Esen-Danaci A, Sarandöl A, Taneli F, Yurtsever F, Ozlen N (2008) Effects of second generation antipsychotics on leptin and ghrelin. Prog Neuro-Psychoph 32:1434-1438
17. Fernø J, Varela L, Skrede S, Vázquez MJ, Nogueiras R, Diéguez C, Vidal-Puig A, Steen VM, López M (2011) Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS ONE 6:e20571
18. Guan X-M, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJS, Smith RG, Van Der Ploeg LHT, Howard AD (1997) Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 48:23-29
19. Han M, Deng C, Burne THJ, Newell KA, Huang X-F (2008) Short-And long-Term effects of antipsychotic drug treatment on weight gain and H1 receptor expression. Psychoneuroendocrinology 33:569-580
20. Harrold JA, Dovey T, Cai X-J, Halford JCG, Pinkney J (2008) Autoradiographic analysis of ghrelin receptors in the rat hypothalamus. Brain Res 1196:59-64
21. He M, Zhang Q, Wang H, Lian J, Deng C, Huang X-F (2012) Olanzapine treatment and time-dependent changes of hypothalamic AMPK-ACC-CPT1 signalling, food intake and body weight in rats. Australian Neuroscience Society 32nd Annual Meeting, Jan-Feb 2012, Gold Coast, Australia:148-148
22. Hosojima H, Togo T, Odawara T, Hasegawa K, Miura S, Kato Y, Kanai A, Kase A, Uchikado H, Hirayasu Y (2006) Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia. J Psychopharmacol 20:75-79
23. Huang X-F, Han M, Huang X, Zavitsanou K, Deng C (2006) Olanzapine differentially affects 5-HT2A and 2C receptor mRNA expression in the rat brain. Behav Brain Res 171:355-362
24. Kapur S, Mamo D (2003) Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog Neuro-Psychoph 27:1081-1090
25. Kern A, Albarran-Zeckler R, Walsh H, Smith R (2012) Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 73:317-332
26. Kim B-J, Sohn J-W, Park C-S, Hahn G-H, Koo J, Noh Y-D, Lee C-S (2008) Body weight and plasma levels of ghrelin and leptin during treatment with olanzapine. J Korean Med Sci 23:685-690
27. Kim H-J, Kobayashi M, Sasaki T, Kikuchi O, Amano K, Kitazumi T, Lee Y-S, Yokota-Hashimoto H, Susanti VY, Kitamura YI, Nakae J, Kitamura T (2012) Overexpression of FoxO1 in the hypothalamus and pancreas causes obesity and glucose intolerance. Endocrinology 153:659-671
28. Kim M-S, Pak YK, Jang P-G, Namkoong C, Choi Y-S, Won J-C, Kim K-S, Kim S-W, Kim H-S, Park J-Y, Kim Y-B, Lee K-U (2006) Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat Neurosci 9:901-906
29. Kitamura T, Feng Y, Ido Kitamura Y, Chua SC, Xu AW, Barsh GS, Rossetti L, Accili D (2006) Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat Med 12:534-540
30. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
31. Kola B, Hubina E, Tucci SA, Kirkham TC, Garcia EA, Mitchell SE, Williams LM, Hawley SA, Hardie DG, Grossman AB, Korbonits Mr (2005) Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-Activated protein kinase. J Biol Chem 280:25196-25201
32. Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S (2010) Olanzapine vs. other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 3:CD006654
33. Lage R, Vázquez MJ, Varela L, Saha AK, Vidal-Puig A, Nogueiras R, Diéguez C, López M (2010) Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB J 24:2670-2679
34. Leucht S, Komossa K, Rummel-Kluge C, Corves C, Hunger H, Schmid F, Asenjo Lobos C, Schwarz S, Davis JM (2009) A meta-Analysis of head-To-head comparisons of secondgeneration antipsychotics in the treatment of schizophrenia. Am J Psychiat 166:152-163
35. Lian J, Huang X-F, Pai N, Deng C (2013) Effects of olanzapine and betahistine co-Treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density. Prog Neuro-Psychoph 47:62-68
36. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RSE, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New Engl J Med 353:1209-1223
37. López M et al. (2008) Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab 7:389-399
38. Martins L, Fernandez-Mallo D, Novelle MG, Vazquez MJ, Tena-Sempere M, Nogueiras R, Lopez M, Dieguez C (2012) Hypothalamic mTOR signaling mediates the orexigenic action of ghrelin. PLoS ONE 7:e46923
39. Moulin A, Brunel L, Boeglin D, Demange L, Ryan J, M'Kadmi C, Denoyelle S, Martinez J, Fehrentz J-A (2013) The 1,2,4-Triazole as a scaffold for the design of ghrelin receptor ligands: Development of JMV 2959, a potent antagonist. Amino Acids 44:301-314
40. Murashita M, Kusumi I, Inoue T, Takahashi Y, Hosoda H, Kangawa K, Koyama T (2005) Olanzapine increases plasma ghrelin level in patients with schizophrenia. Psychoneuroendocrinology 30:106-110
41. Murashita M, Inoue T, Kusumi I, Nakagawa S, Itoh K, Tanaka T, Izumi T, Hosoda H, Kangawa K, Koyama T (2007) Glucose and lipid metabolism of long-Term risperidone monotherapy in patients with schizophrenia. Psychiat Clin Neuros 61:54-58
42. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S (2001) A role for ghrelin in the central regulation of feeding. Nature 409:194-198
43. Nogueiras R, López M, Lage R, Perez-Tilve D, Pfluger P, Mendieta-Zerón H, Sakkou M, Wiedmer P, Benoit SC, Datta R, Dong JZ, Culler M, Sleeman M, Vidal-Puig A, Horvath T, Treier M, Diéguez C, Tschöp MH (2008) Bsx, a novel hypothalamic factor linking feeding with locomotor activity, is regulated by energy availability. Endocrinology 149:3009-3015
44. Pai N, Deng C, Vella S-L, Castle D, Huang X-F (2012) Are there different neural mechanisms responsible for three stages of weight gain development in anti-psychotic therapy: Temporally based hypothesis. Asian J Psychiatry 5:315-318
45. Palik E, Birkás KD, Faludi G, Karádi I, Cseh K (2005) Correlation of serum ghrelin levels with body mass index and carbohydrate metabolism in patients treated with atypical antipsychotics. Diabetes Res Clin Pr 68:S60-S64
46. Paxions G, Watson C (2007) The rat brain in stereotaxic coordinates, 2nd edn. Sydney: Academic
47. Perez-Iglesias R, Vazquez-Barquero JL, Amado JA, Berja A, Garcia-Unzueta MT, Pelayo-Terán JM, Carrasco-Marín E, Mata I, Crespo-Facorro B (2008) Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment. J Clin Psychopharm 28:289-95
48. Ramirez S, Martins L, Jacas J, Carrasco P, Pozo M, Clotet J, Serra D, Hegardt FG, Dieguez C, Lopez M, Casals N (2013) Hypothalamic ceramide levels regulated by CPT1C mediate the orexigenic effect of ghrelin. Diabetes 62(7):2329-37
49. Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659-661
50. Roerig JL, Steffen KJ, Mitchell JE, Crosby RD, Gosnell BA (2008) A comparison of the effects of olanzapine and risperidone vs. placebo on ghrelin plasma levels. J Clin Psychopharm 28:21-6
51. Romero-Pico A, Novelle MG, Folgueira C, Lopez M, Nogueiras R, Diaguez C (2013) Central manipulation of dopamine receptors attenuates the orexigenic action of ghrelin. Psychopharmacology 229:275-283
52. Sakkou M, Wiedmer P, Anlag K, Hamm A, Seuntjens E, Ettwiller L, Tschöp Matthias H, Treier M (2007) A role for brain-specific homeobox factor Bsx in the control of hyperphagia and locomotory behavior. Cell Metab 5:450-463
53. Schellekens H, van Oeffelen WEPA, Dinan TG, Cryan JF (2013) Promiscuous Dimerization of the Growth Hormone Secretagogue Receptor (GHS-R1a) attenuates ghrelin-mediated signaling. J Biol Chem 288:181-191
54. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, TakayaK,HayashiT, Inoue G,HosodaK,KojimaM,KangawaK, Nakao K (2001) Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50:227-232
55. Skrede S, Martins L, Berge RK, Steen VM, Lopez M, Ferno J (2014) Olanzapine depot formulation in rat: A step forward in modelling antipsychotic-induced metabolic adverse effects. Int J Neuropsychopharmacol FirstView: 71(1):91-104
56. Smith GC, Vickers MH, Shepherd PR (2011) Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat. Arch Physiol Biochem 117:241-249
57. Stefanidis A, Verty ANA, Allen AM, Owens NC, Cowley MA, Oldfield BJ (2009) The role of thermogenesis in antipsychotic drug-induced weight gain. Obesity 17:16-24
58. Tanaka K,MorinobuS, IchimuraM, Asakawa A, Inui A,HosodaH, Kangawa K, Yamawaki S (2008) Decreased levels of ghrelin, cortisol, and fasting blood sugar, but not n-octanoylated ghrelin, in Japanese schizophrenic inpatients treated with olanzapine. Prog Neuro-Psychoph 32:1527-1532
59. Togo T, Hasegawa K, Miura S, Hosojima H, Kojima K, Shoji M, Kase A, Uchikado H, Iseki E, Kosaka K (2004) Serum ghrelin concentrations in patients receiving olanzapine or risperidone. Psychopharmacology 172:230-232
60. Ueno S, Yoshida S, Mondal A, Nishina K, Koyama M, Sakata I, Miura K, Hayashi Y, Nemoto N, Nishigaki K, Sakai T (2012) In vitro selection of a peptide antagonist of growth hormone secretagogue receptor using cDNA display. Proc Natl Acad Sci USA 109:11121-11126
61. van Der Zwaal EM, Luijendijk MCM, Evers SS, la Fleur SE, Adan RAH (2010) Olanzapine affects locomotor activity and meal size in male rats. Pharmacol Biochem Be 97:130-137
62. Velasquez DA, Martinez G, Romero A, Vazquez MJ, Boit KD, Dopeso-Reyes IG, Lopez M, Vidal A, Nogueiras R, Dieguez C (2011) The central Sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin. Diabetes 60:1177-1185
63. Vidarsdottir S, Roelfsema F, Streefland T, Holst JJ, Rehfeld JF, Pijl H (2010) Short-Term treatment with olanzapine does not modulate gut hormone secretion: Olanzapine disintegrating vs. standard tablets. Eur J Endocrinol 162:75-83
64. Weston-Green K, Huang X-F, Deng C (2011) Olanzapine treatment and metabolic dysfunction: A dose response study in female Sprague Dawley rats. Behav Brain Res 217:337-346
65. Weston-Green K, Huang X-F, Deng C (2012a) Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain. PLoS ONE 7:e33548
66. Weston-Green K, Huang X-F, Lian J, Deng C (2012b) Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels. Eur Neuropsychopharm 22:364-373
67. Wortley KE, Anderson KD, Garcia K, Murray JD, Malinova L, Liu R, Moncrieffe M, Thabet K, Cox HJ, Yancopoulos GD, Wiegand SJ, Sleeman MW (2004) Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 101:8227-8232
68. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR (2001) Ghrelin causes hyperphagia and obesity in rats. Diabetes 50:2540-2547
69. Zaniolo K, Sapieha P, Shao Z, Stahl A, Zhu T, Tremblay S, Picard E, Madaan A, Blais M, Lachapelle P, Mancini J, Hardy P, Smith LEH, Ong H, Chemtob S (2011) Ghrelin modulates physiologic and pathologic retinal angiogenesis through GHSR-1a. Invest Ophth Vis Sci 52:5376-5386
70. Zhang Q, Deng C, Huang X-F (2013) The role of ghrelin signalling in second-generation antipsychotic-induced weight gain. Psychoneuroendocrinology 38(11):2423-38
71. Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK (2006) Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 494:528-548